Skip to main content
logo
iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.430
-0.040 (-2.72%)
Aug 21, 2026, 4:00 PM EDT - Market closed

iBio, Inc. Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
0.30.40.23-1.882.37
Revenue Growth
-20.00%77.78%---20.54%44.75%
Gross Profit
0.30.40.23-1.880.91
Operating Income
-28.96-18.6-16.63-28.78-29.7-30.97
Net Income
-27.61-18.38-24.91-65.01-50.39-23.47
Earnings Per Share
-0.39-1.75-6.50-106.23-115.56-59.98
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
74.88.5814.214.333.5296.97
Total Debt
2.333.574.8217.4825.7732.72
Net Cash (Debt)
72.475.019.39-13.177.7664.25
Net Cash Growth
11241.47%-46.62%---87.93%189.37%
Net Cash Per Share
1.020.482.45-21.5317.78164.22

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-21.61-15.3-18.55-30.44-37.48-30.06
Capital Expenditures
-0.56-0.02-0.21-6.43-7.33-4.92
Free Cash Flow
-22.17-15.32-18.76-36.87-44.81-34.98
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%-100.00%38.34%
Operating Margin
-9653.00%-4650.50%-7392.89%--1576.27%-1306.12%
Pretax Margin
-9202.00%-4594.25%-6863.56%--1566.51%-979.04%
Profit Margin
-9202.00%-4594.25%-11069.78%--2674.68%-989.75%
FCF Margin
-7388.33%-3830.00%-8339.56%--2378.45%-1475.50%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
236.8030.9480.87-30.57138.74